Infection with persistent viruses such as herpesviruses, hepatitis B and C and HIV presents a significant clinical problem. T cell exhaustion can contribute to viral persistence or reactivation and it is therefore important to understand why this occurs and to identify the underlying defects in the immune response. Failure to control some of these viruses, including the gammaherpesviruses, is particularly problematic in immunocompromised individuals such as AIDS patients or transplant recipients who lack effective CD4 T cell function. Murine gammaherpesvirus-68 (MHV-68) is a naturally-occurring rodent pathogen, which is closely related to the human pathogens Epstein Barr virus (EBV) and Kaposi?s sarcoma-associated herpesvirus (KSHV). Infection of mice with MHV-68 provides a tractable and well-characterized small animal model for studying the immunological control of gammaherpesvirus infection and the effects of defective CD4 T cell help on other components of the immune system. CD4 T cells are not required for acute control of replicating MHV-68, but are required for effective long-term control. Our early work highlighted the importance of CD40-CD40L interactions in CD4 T cell help in the long-term control of MHV-68 and showed that CD40 stimulation alone, using agonistic antibodies, was sufficient to prevent viral reactivation in the lungs of CD4 T cell deficient mice. CD40 stimulation upregulates CD80 and 86 on dendritic cells, which interact with positive and negative costimulators CD28 and CTLA-4, respectively. Interestingly, we have shown that, although CD80 and 86 are essential for long-term control of MHV-68, CD28, the only known positive costimulatory receptor for CD80/86 is not required, suggesting the possibility of a novel receptor. CD28, CD80 and 86 are part of the CD28-B7 superfamily, which comprises several members that mediate positive or negative costimulation of T cells. In this application, we will investigate the mechanisms by which CD40 and CD28-B7 family members interact to regulate CD8 T cell responses during the response to gammaherpesvirus infection.
In Aim 1 we will investigate why CD4 T cells are required for the long-term control of MHV-68, but are not essential for shortterm (acute) control of the virus. Our data suggests that two alternative pathways of CD8 T cell activation function during acute, but not during long-term control.
In Aim 2 we will investigate the possibility that a novel receptor for CD80/86 (B7-1, 2) functions in the long-term control of MHV-68.
In Aim 3, we will investigate the role of PD-1, an inhibitory B7 family member that we have shown is upregulated on CD8 T cells in the absence of CD4 T cells, in acute and long-term control of MHV-68. These studies will provide important insight into differences in the mechanisms by which CD8 T cells mediate acute and long-term control of persistent viral infections and may be of significant value in designing immunotherapeutic agents or vaccines to combat persistent infections. The results obtained may have broader significance in understanding the mechanisms controlling T cell activation or tolerance, in general.

Public Health Relevance

Infections with persistent viruses such as EBV, CMV, hepatitis B and C and HIV present a significant clinical problem. It is therefore important to understand why the immune system fails to control these viruses. As some persistent viruses are particularly problematic in immunocompromised individuals such as AIDS patients or transplant recipients who lack effective CD4 T cell function, we will investigate how lack of CD4 T cell help affects other components of the immune system and how a persistent virus is controlled in individuals with a normal immune system. These studies will further our understanding of viral pathogenesis and may assist in the design of vaccines and other therapeutic interventions to control persistent viral infections. In addition, some of the mechanisms that turn components of the immune system on or off during persistent viral infections may also be involved in acute viral infections or autoimmune responses.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI050810-08
Application #
7860367
Study Section
Virology - B Study Section (VIRB)
Program Officer
Lapham, Cheryl K
Project Start
2001-12-01
Project End
2012-05-31
Budget Start
2010-06-01
Budget End
2012-05-31
Support Year
8
Fiscal Year
2010
Total Cost
$450,000
Indirect Cost
Name
Torrey Pines Institute for Molecular Studies
Department
Type
DUNS #
605758754
City
Port Saint Lucie
State
FL
Country
United States
Zip Code
34987